Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System
Article in Pharmaceuticals (March 2024)
The most recent citing publications are shown below. View all 40 publications that cite this research output on Dimensions.
Article in Pharmaceuticals (March 2024)
Preprint in Research Square (October 2023)
Article in European Journal of Business and Management Research (December 2022)